Cargando…

Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model

Carboxy-dehydroevodiamine·HCl (cx-DHED) is a derivative of DHED, which improves memory impairment. Carboxyl modification increases solubility in water, indicating that its bioavailability is higher than that of DHED. Cx-DHED is expected to have better therapeutic effects on Alzheimer's disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Shinwoo, Ha, Sungji, Park, Hyunjun, Nam, Eunjoo, Suh, Won Hyuk, Suh, Yoo-Hun, Chang, Keun-A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243640/ https://www.ncbi.nlm.nih.gov/pubmed/30483077 http://dx.doi.org/10.3389/fnbeh.2018.00273

Ejemplares similares

The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer’s Disease
por: Park, Hyunjun, et al.
Publicado: (2019)

Region-specific amyloid-β accumulation in the olfactory system influences olfactory sensory neuronal dysfunction in 5xFAD mice
por: Son, Gowoon, et al.
Publicado: (2021)

Dehydroevodiamine·HCl enhances cognitive function in memory-impaired rat models
por: Shin, Ki Young, et al.
Publicado: (2017)

Dehydroevodiamine·HCl Improves Stress-Induced Memory Impairments and Depression Like Behavior in Rats
por: Kim, Hee Jin, et al.
Publicado: (2014)

Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model
por: Kim, Jinho, et al.
Publicado: (2022)

Long-Term Treatment of Cuban Policosanol Attenuates Abnormal Oxidative Stress and Inflammatory Response via Amyloid Plaques Reduction in 5xFAD Mice
por: Kim, Jin-Ho, et al.
Publicado: (2021)

miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease
por: Park, Hyunjun, et al.
Publicado: (2022)

Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
por: Wang, Lu, et al.
Publicado: (2016)

Axonal and myelinic pathology in 5xFAD Alzheimer’s mouse spinal cord
por: Chu, Tak-Ho, et al.
Publicado: (2017)

Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer’s disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2021)

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
por: Forner, Stefania, et al.
Publicado: (2021)

Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model
por: Jeong, Ye Ji, et al.
Publicado: (2021)

PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions
por: Tible, Marion, et al.
Publicado: (2019)

Caspase-6 Knockout in the 5xFAD Model of Alzheimer’s Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks
por: Angel, Ariel, et al.
Publicado: (2020)

Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease
por: Andersen, Jens V., et al.
Publicado: (2021)

Degenerate mapping of environmental location presages deficits in object-location encoding and memory in the 5xFAD mouse model for Alzheimer’s disease
por: Zhang, Hai, et al.
Publicado: (2023)

Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2020)

Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer’s disease
por: Jullienne, Amandine, et al.
Publicado: (2023)

1950 MHz radiofrequency electromagnetic fields do not aggravate memory deficits in 5xFAD mice
por: Son, Yeonghoon, et al.
Publicado: (2016)

Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
por: Shen, Guofang, et al.
Publicado: (2020)

Impact of Gut Microbiome Manipulation in 5xFAD Mice on Alzheimer’s Disease-Like Pathology
por: Guilherme, Malena dos Santos, et al.
Publicado: (2021)

Brain and Retinal Abnormalities in the 5xFAD Mouse Model of Alzheimer's Disease at Early Stages
por: Zhang, Mengrong, et al.
Publicado: (2021)

Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Karaahmet, Berke, et al.
Publicado: (2023)

Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ
por: Jo, Kyung Won, et al.
Publicado: (2022)

New Positive TRPC6 Modulator Penetrates Blood–Brain Barrier, Eliminates Synaptic Deficiency and Restores Memory Deficit in 5xFAD Mice
por: Zernov, Nikita, et al.
Publicado: (2022)

JNK Activation Correlates with Cognitive Impairment and Alteration of the Post-Synaptic Element in the 5xFAD AD Mouse Model
por: Priori, Erica Cecilia, et al.
Publicado: (2023)

Can MRI T(1) be used to detect early changes in 5xFAD Alzheimer’s mouse brain?
por: Spencer, Nicholas G., et al.
Publicado: (2016)

Rod pathway and cone pathway retinal dysfunction in the 5xFAD mouse model of Alzheimer’s disease
por: McAnany, J. Jason, et al.
Publicado: (2021)

Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Belaya, Irina, et al.
Publicado: (2021)

Meridianins Rescue Cognitive Deficits, Spine Density and Neuroinflammation in the 5xFAD Model of Alzheimer’s Disease
por: Rodríguez-Urgellés, Ened, et al.
Publicado: (2022)

Impact of the Age of Cecal Material Transfer Donors on Alzheimer’s Disease Pathology in 5xFAD Mice
por: Valeri, Francesco, et al.
Publicado: (2021)

Primary Cilia Structure Is Prolonged in Enteric Neurons of 5xFAD Alzheimer’s Disease Model Mice
por: Nguyen, Vu Thu Thuy, et al.
Publicado: (2021)

Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer’s disease
por: Zhukov, Oleg, et al.
Publicado: (2023)

Cyclopentanone Derivative Attenuates Memory Impairment by Inhibiting Amyloid Plaques Formation in the 5xFAD Mice
por: Ullah, Rahim, et al.
Publicado: (2021)

Visuo‐spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments
por: O'Leary, Timothy P., et al.
Publicado: (2022)

Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice
por: Prange-Kiel, Janine, et al.
Publicado: (2016)

Synthetic PPAR Agonist DTMB Alleviates Alzheimer’s Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
por: Oh, Eunji, et al.
Publicado: (2022)

Increased central auditory gain in 5xFAD Alzheimer’s disease mice as an early biomarker candidate for Alzheimer’s disease diagnosis
por: Na, Daxiang, et al.
Publicado: (2023)

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer’s Disease Pathology in 5xFAD Model Mice
por: dos Santos Guilherme, Malena, et al.
Publicado: (2020)

TMEM59 Haploinsufficiency Ameliorates the Pathology and Cognitive Impairment in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Meng, Jian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qf3l39drf0vivtnl8tf1d2kaas